a:5:{s:8:"template";s:12359:"<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="utf-8"/>
<meta content="initial-scale=1, width=device-width" name="viewport"/>
<title>{{ keyword }}</title>
<link href="https://fonts.googleapis.com/css?family=Droid+Serif:400,400italic,700,700italic&amp;subset=latin%2Clatin-ext" id="wp-garden-droid-font-css" media="all" rel="stylesheet" type="text/css"/>
<link href="https://fonts.googleapis.com/css?family=Shadows+Into+Light&amp;subset=latin%2Clatin-ext" id="wp-garden-shadows-font-css" media="all" rel="stylesheet" type="text/css"/>
<link href="http://fonts.googleapis.com/css?family=Open+Sans%3A300%2C400%2C600%2C700%2C800%2C300italic%2C400italic%2C600italic%2C700italic%2C800italic%7CRaleway%3A100%2C200%2C300%2C400%2C500%2C600%2C700%2C800%2C900&amp;ver=5.4" id="redux-google-fonts-smof_data-css" media="all" rel="stylesheet" type="text/css"/></head>
<style rel="stylesheet" type="text/css">@charset "UTF-8";.has-drop-cap:not(:focus):first-letter{float:left;font-size:8.4em;line-height:.68;font-weight:100;margin:.05em .1em 0 0;text-transform:uppercase;font-style:normal} html{font-family:sans-serif;-webkit-text-size-adjust:100%;-ms-text-size-adjust:100%}body{margin:0}article,aside,footer,header,nav{display:block}a{background-color:transparent}a:active,a:hover{outline:0}/*! Source: https://github.com/h5bp/html5-boilerplate/blob/master/src/css/main.css */@media print{*,:after,:before{color:#000!important;text-shadow:none!important;background:0 0!important;-webkit-box-shadow:none!important;box-shadow:none!important}a,a:visited{text-decoration:underline}a[href]:after{content:" (" attr(href) ")"}a[href^="#"]:after{content:""}h3{orphans:3;widows:3}h3{page-break-after:avoid}} *{-webkit-box-sizing:border-box;-moz-box-sizing:border-box;box-sizing:border-box}:after,:before{-webkit-box-sizing:border-box;-moz-box-sizing:border-box;box-sizing:border-box}html{font-size:10px;-webkit-tap-highlight-color:transparent}body{font-family:"Helvetica Neue",Helvetica,Arial,sans-serif;font-size:14px;line-height:1.42857143;color:#333;background-color:#fff}a{color:#337ab7;text-decoration:none}a:focus,a:hover{color:#23527c;text-decoration:underline}a:focus{outline:thin dotted;outline:5px auto -webkit-focus-ring-color;outline-offset:-2px}h3{font-family:inherit;font-weight:500;line-height:1.1;color:inherit}h3{margin-top:20px;margin-bottom:10px}h3{font-size:24px}.text-left{text-align:left}ul{margin-top:0;margin-bottom:10px}.container{padding-right:15px;padding-left:15px;margin-right:auto;margin-left:auto}@media (min-width:768px){.container{width:750px}}@media (min-width:992px){.container{width:970px}}@media (min-width:1200px){.container{width:1170px}}.row{margin-right:-15px;margin-left:-15px}.col-lg-3,.col-lg-6,.col-lg-9,.col-md-3,.col-md-6,.col-md-9,.col-sm-12,.col-sm-3,.col-sm-6,.col-sm-9,.col-xs-12{position:relative;min-height:1px;padding-right:15px;padding-left:15px}.col-xs-12{float:left}.col-xs-12{width:100%}@media (min-width:768px){.col-sm-12,.col-sm-3,.col-sm-6,.col-sm-9{float:left}.col-sm-12{width:100%}.col-sm-9{width:75%}.col-sm-6{width:50%}.col-sm-3{width:25%}}@media (min-width:992px){.col-md-3,.col-md-6,.col-md-9{float:left}.col-md-9{width:75%}.col-md-6{width:50%}.col-md-3{width:25%}}@media (min-width:1200px){.col-lg-3,.col-lg-6,.col-lg-9{float:left}.col-lg-9{width:75%}.col-lg-6{width:50%}.col-lg-3{width:25%}}.collapse{display:none}.navbar-collapse{padding-right:15px;padding-left:15px;overflow-x:visible;-webkit-overflow-scrolling:touch;border-top:1px solid transparent;-webkit-box-shadow:inset 0 1px 0 rgba(255,255,255,.1);box-shadow:inset 0 1px 0 rgba(255,255,255,.1)}@media (min-width:768px){.navbar-collapse{width:auto;border-top:0;-webkit-box-shadow:none;box-shadow:none}.navbar-collapse.collapse{display:block!important;height:auto!important;padding-bottom:0;overflow:visible!important}}.clearfix:after,.clearfix:before,.container:after,.container:before,.navbar-collapse:after,.navbar-collapse:before,.row:after,.row:before{display:table;content:" "}.clearfix:after,.container:after,.navbar-collapse:after,.row:after{clear:both}@-ms-viewport{width:device-width}  body{font-family:'Open Sans';color:#767676;background-attachment:fixed;background-size:cover;background-position:center}a{color:#6f4792}a:hover{color:#6ab42f}article,aside,body,div,footer,h3,header,html,i,li,nav,span,ul{-moz-osx-font-smoothing:grayscale;text-rendering:optimizelegibility}#cshero-header-navigation{position:static}h3{margin:0 0 10px;line-height:1.8}#cshero-footer-top{padding:83px 0 81px}#cshero-footer-top .cms-recent-posts article{position:relative;margin-bottom:25px}#cshero-footer-top h3.wg-title{color:#fff;font-size:21px!important;font-weight:700;margin-bottom:30px!important}#cshero-footer-bottom{border-top:1px solid #333;color:#767676;padding:29px 0 28px;font-weight:600!important}#cshero-header{width:100%;position:relative}#cshero-header nav.main-navigation ul.menu-main-menu>li>a{line-height:103px}#cshero-header-top{background-color:#6ab42f}#cshero-header{height:103px;background-color:#fff}#cshero-header #cshero-header-logo a{line-height:103px;-webkit-transition:line-height .4s ease-in-out;-khtml-transition:line-height .4s ease-in-out;-moz-transition:line-height .4s ease-in-out;-ms-transition:line-height .4s ease-in-out;-o-transition:line-height .4s ease-in-out;transition:line-height .4s ease-in-out}#cshero-header #cshero-header-logo a:focus{outline:0}#cshero-header #cshero-header-navigation{-webkit-transition:line-height .1s ease-in-out;-khtml-transition:line-height .1s ease-in-out;-moz-transition:line-height .1s ease-in-out;-ms-transition:line-height .1s ease-in-out;-o-transition:line-height .1s ease-in-out;transition:line-height .1s ease-in-out}#cshero-header #cshero-header-navigation nav#site-navigation{float:right}#cshero-header #cshero-header-navigation nav#site-navigation ul#menu-primary-menu>li>a{color:#222}#cshero-header #cshero-header-navigation nav#site-navigation ul#menu-primary-menu>li>a span{padding:7.7px 15px}#cshero-header #cshero-header-navigation nav#site-navigation ul#menu-primary-menu>li>a:hover{color:#fff}#cshero-header #cshero-header-navigation nav#site-navigation ul#menu-primary-menu>li>a:hover span{background-color:#6ab42f}#cshero-header #cshero-header-navigation nav#site-navigation ul#menu-primary-menu>li>a:focus{outline:0;text-decoration:none}#cshero-header #cshero-menu-mobile i{display:none}@media screen and (max-width:991px){#cshero-header{height:60px}#cshero-header #cshero-header-logo a{line-height:60px}#cshero-header #cshero-menu-mobile{float:right;position:absolute;right:15px;top:50%;-webkit-transform:translatey(-50%);-khtml-transform:translatey(-50%);-moz-transform:translatey(-50%);-ms-transform:translatey(-50%);-o-transform:translatey(-50%);transform:translatey(-50%)}#cshero-header #cshero-menu-mobile i{display:block!important;padding:0 0 0 30px}}@media screen and (min-width:992px){#cshero-header-navigation .main-navigation ul{margin:0;text-indent:0}#cshero-header-navigation .main-navigation li a{border-bottom:0;white-space:nowrap}#cshero-header-navigation .main-navigation .menu-main-menu>li{vertical-align:top}#cshero-header-navigation .main-navigation .menu-main-menu>li>a{position:relative;text-align:center;line-height:1.1;-webkit-transition:all .4s ease 0s;-khtml-transition:all .4s ease 0s;-moz-transition:all .4s ease 0s;-ms-transition:all .4s ease 0s;-o-transition:all .4s ease 0s;transition:all .4s ease 0s}#cshero-header-navigation .main-navigation .menu-main-menu>li:last-child>a{padding-right:0}#cshero-header-navigation .main-navigation .menu-main-menu>li,#cshero-header-navigation .main-navigation .menu-main-menu>li a{display:inline-block;text-decoration:none}}@media screen and (max-width:991px){.cshero-main-header .container{position:relative}#cshero-menu-mobile{display:block}#cshero-header-navigation{display:none}#cshero-menu-mobile{display:block}#cshero-menu-mobile i{color:inherit;cursor:pointer;font-size:inherit;line-height:35px;text-align:center}#cshero-header #cshero-header-navigation .main-navigation{padding:15px 0}#cshero-header #cshero-header-navigation .main-navigation .menu-main-menu li{line-height:31px}#cshero-header #cshero-header-navigation .main-navigation .menu-main-menu li a{background:0 0;color:#fff}#cshero-header-navigation .main-navigation .menu-main-menu>li{position:relative}#cshero-header-navigation .main-navigation .menu-main-menu>li a{display:block;border-bottom:none;font-size:14px;color:#222}}@media screen and (max-width:991px){#cshero-footer-bottom .footer-bottom-widget{text-align:center}#cshero-footer-top .widget-footer{height:270px;margin-bottom:40px}}@media screen and (max-width:767px){#cshero-footer-top .widget-footer{padding-top:40px}}.container:after,.navbar-collapse:after,.row:after{clear:both}.container:after,.container:before,.navbar-collapse:after,.navbar-collapse:before,.row:after,.row:before{content:" ";display:table}.vc_grid.vc_row .vc_pageable-slide-wrapper>:hover{z-index:3} @font-face{font-family:'Open Sans';font-style:normal;font-weight:400;src:local('Open Sans Regular'),local('OpenSans-Regular'),url(http://fonts.gstatic.com/s/opensans/v17/mem8YaGs126MiZpBA-UFVZ0e.ttf) format('truetype')} @font-face{font-family:Raleway;font-style:normal;font-weight:400;src:local('Raleway'),local('Raleway-Regular'),url(http://fonts.gstatic.com/s/raleway/v14/1Ptug8zYS_SKggPNyC0ISg.ttf) format('truetype')}@font-face{font-family:Raleway;font-style:normal;font-weight:500;src:local('Raleway Medium'),local('Raleway-Medium'),url(http://fonts.gstatic.com/s/raleway/v14/1Ptrg8zYS_SKggPNwN4rWqZPBQ.ttf) format('truetype')} @font-face{font-family:Roboto;font-style:normal;font-weight:500;src:local('Roboto Medium'),local('Roboto-Medium'),url(http://fonts.gstatic.com/s/roboto/v20/KFOlCnqEu92Fr1MmEU9fBBc9.ttf) format('truetype')} @font-face{font-family:Raleway;font-style:normal;font-weight:500;src:local('Raleway Medium'),local('Raleway-Medium'),url(http://fonts.gstatic.com/s/raleway/v14/1Ptrg8zYS_SKggPNwN4rWqZPBQ.ttf) format('truetype')}</style>
<body class="wpb-js-composer js-comp-ver-4.10 vc_responsive">
<div class="" id="page">
<header class="site-header" id="masthead">
<div id="cshero-header-top" style="display:">
<div class="container">
<div class="row">
</div>
</div>
</div>
<div class="cshero-main-header no-sticky " id="cshero-header">
<div class="container">
<div class="row">
<div class="col-xs-12 col-sm-3 col-md-3 col-lg-3" id="cshero-header-logo">
<a href="#">{{ keyword }}</a>
</div>
<div class="col-xs-12 col-sm-9 col-md-9 col-lg-9 megamenu-off" id="cshero-header-navigation">
<nav class="main-navigation" id="site-navigation">
<div class="menu-primary-menu-container"><ul class="nav-menu menu-main-menu" id="menu-primary-menu"><li class="menu-item menu-item-type-custom menu-item-object-custom menu-item-home menu-item-1276" id="menu-item-1276"><a href="#"><span>Home</span></a></li>
<li class="menu-item menu-item-type-post_type menu-item-object-page menu-item-1437" id="menu-item-1437"><a href="#"><span>Our Services</span></a></li>
<li class="menu-item menu-item-type-post_type menu-item-object-page menu-item-1456" id="menu-item-1456"><a href="#"><span>About us</span></a></li>
<li class="menu-item menu-item-type-post_type menu-item-object-page menu-item-1278" id="menu-item-1278"><a href="#"><span>Blog</span></a></li>
<li class="menu-item menu-item-type-post_type menu-item-object-page menu-item-1325" id="menu-item-1325"><a href="#"><span>Contact</span></a></li>
</ul></div> </nav>
</div>
<div class="collapse navbar-collapse" id="cshero-menu-mobile"><i class="fa fa-bars"></i></div>
</div>
</div>
</div>
 </header>
<div id="main">
{{ text }}
</div>
<footer>
<div id="cshero-footer-top">
<div class="container">
<div class="row">
<div class="col-xs-12 col-sm-6 col-md-3 col-lg-3 widget-footer"><aside class="widget cms-recent-posts" id="cms_recent_posts-4"><h3 class="wg-title">Recent Posts</h3> <article class="recent-post-item clearfix post-890 post type-post status-publish format-standard has-post-thumbnail hentry category-lawn-maintenance tag-lawn-care">
{{ links }}
</article>
</aside></div>
</div>
</div>
</div>
<div id="cshero-footer-bottom">
<div class="container">
<div class="row">
<div class="col-xs-12 col-sm-12 col-md-6 col-lg-6 footer-bottom-widget text-left">{{ keyword }} 2021</div>
</div>
</div>
</div>
</footer>
</div>
</body></html>";s:4:"text";s:13596:"The persistence of secondary hyperparathyroidism after renal transplantation is frequent and often complicated by overt hypercalcemia. This topic reviews the management of secondary hyperparathyroidism in dialysis patients … Primary hyperparathyroidism: Diagnosis, differential diagnosis, and evaluation View in Chinese Stillion J R, Ritt M G (2009) Renal secondary hyperparathyroidism in dogs. Secondary hyperparathyroidism is defined as adaptive parathyroid gland hyperplasia and increased production of PTH. It is differentiated from primary hyperparathyroidism by a history of chronic kidney failure and secondary hyperparathyroidism. When patients have been on dialysis for many years or cincalcet is unable to control PTH production, the PTH levels can be extremely high and may require parathyroid surgery. Patients with kidney disease can develop a bone disease (renal osteodystrophy) which, may cause bone pain, weakness and fractures resulting from the failure of the kidneys to maintain normal phosphate and calcium levels. Secondary hyperparathyroidism is usually due to renal disease and is relatively common in the age of hemodialysis and renal transplantation. Kidney: chronic renal failure - interstitial nephritis 01. The code N25.81 is valid during the fiscal year 2021 from October 01, 2020 through September 30, 2021 for the submission of HIPAA-covered transactions. Almost all people with end-stage renal disease (ESRD) have secondary hyperparathyroidism. Secondary hyperparathyroidism (SHPT) is characterized by pronounced parathyroid gland hyperplasia resulting from end-organ resistance to parathyroid hormone (PTH). This in turn results in chronic hypercalaemia. Abnormal calcium and phosphorous levels in the blood and tissues occur in chronic kidney disease. Secondary hyperparathyroidism (SHPT) is a major complication for patients with chronic renal failure on long-term dialysis. You may develop bone complications such as osteopaenia or osteoporosis and the symptoms related to that. Valid for Submission. Hyperparathyroidism is when your parathyroid glands create too much parathyroid hormone in the bloodstream. Tertiary hyperparathyroidism has a high PTH and a high serum calcium. Hypocalcaemia will elevate PTH levels and can serve as a cause of secondary hyperparathyroidism. Two UK studies have estimated the annual incidence of ESRD to be 132 and 148 per million population. from patients with chronic renal failure contained one- pressing secondary hyperparathyroidism (SH) when the PTH levels are extremely high (.1500). Untreated secondary hyperparathyroidism can increase the risk of broken bones. In Secondary Hyperparathyroidism, you will have symptoms of low, NOT high, calcium which can be seen here. Primary hyperparathyroidism is the third most common endocrine disorder with a lifetime risk of 1% (Shindo et al. An increased PTH level can have deleterious effects, including soft tissue mineralization, fibrous osteodystrophy, bone marrow suppression, urolithiasis, and neuropathy. Secondary hyperparathyroidism as a complication of chronic renal failure is a metabolic state characterized by an excessive, but not autonomous, rate of PTH secretion. Secondary hyperparathyroidism is common in people who have kidney failure (stage 5 kidney disease). World J Surg 2012 Jun;36 (6):1314-9. doi: 10.1007/s00268-012-1560-x. This activity provides an overview and update of the pathophysiology and therapy of SHPT. Secondary hyperparathyroidism develops as a compensatory mechanism when the serum calcium level is persistently below normal, as in chronic renal disease, vitamin D deficiency, or intestinal malabsorption syndromes, all of which can cause insufficient absorption of calcium and vitamin D. It happens when your body’s levels of calcium, vitamin D and phosphorus are not in balance. Calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients. Related Images. It is most commonly due to a solitary benign adenoma of either the internal or external par… Parathyroid hormone (PTH) functions to maintain calcium homeostasis by acting on the renal tubules, on calcium stores in the skeletal system, and indirectly on the gastrointestinal (GI) tract through activation of vitamin D and enteral absorption. Postoperative hungry bone syndrome in patients with secondary hyperparathyroidism of renal origin. In kidney disease, your blood phosphate level can be high because your kidneys cannot remove phosphate in your urine. This hormone helps maintain an appropriate balance of calcium in the bloodstream and in tissues that depend on calcium for proper functioning. Renal secondary hyperparathyroidism is a common endocrinopathy that occurs as a consequence of chronic azotemic kidney disease. Secondary hyperparathyroidism is a condition in which too much parathyroid hormone (PTH) is produced. Surgical management represents the only radical treatment of … Recent investigations have shown an effect of the different vitamin D receptor (VDR) genotypes on parathyroid hormone (PTH) secretion in both primary and secondary hyperparathyroidism. It occurs in many veterinary species and can be primary or secondary. The kidney plays a pivotal role in regulating phosphorus balance, as it is the primary route of phosphorus excretion. The burden of disease caused by osteitis fibrosa and mixed These glands, located behind the thyroid at the bottom of your neck, are about the size of a grain of rice. Secondary hyperparathyroidism news, research studies and SHPT clinical treatment articles for the healthcare professional to keep updated on SHPT news. Kidney failure due to high blood calcium is less common than kidney stones, but the consequences are far more severe. Patients with secondary hyperparathyroidism (SHPT) experience worsening of certain symptoms as parathyroid hormone (PTH) levels increase, new data suggest. Compend Contin Educ Vet 31 (6), E8 PubMed. The parathyroid glands produce parathyroid hormone. Renal hyperparathyroidism (rHPT) is a common complication of chronic kidney disease characterized by elevated parathyroid hormone levels secondary to derangements in the homeostasis of calcium, phosphate, and vitamin D. Patients with rHPT experience increased rates of cardiovascular problems and bon …. Nephrocalcinosis (calcification of the kidney) is a completely avoidable complication of hyperparathyroidism. Tertiary hyperparathyroidism occurs when the parathyroids are autonomously over-functioning (this happens in a few patients with secondary hyperparathyroidism). Introduction. Excessive production of this hormone caused by increased activity of these glands is known as hyperparathyroidism. [citation needed]Hyperparathyroidism can cause hyperchloremia and increase renal bicarbonate loss, which may result in a normal anion gap metabolic acidosis. When this occurs in response to low blood calcium caused by another condition, the condition is called secondary hyperparathyroidism. In Brief Secondary hyperparathyroidism (SHPT) describes a complex alteration in bone and mineral metabolism that occurs as a direct result of chronic kidney disease (CKD). Etiology. When a person has secondary hyperparathyroidism, then something is causing the parathyroid glands to become over activ… Hyperparathyroidism is an endocrine disease caused by overactivity of the parathyroid gland and consequent raised body levels of parathyroid hormone (PTH). Secondary hyperparathyroidism is the overproduction of parathyroid hormone secondary to hypocalcemia, typically as a result of vitamin D deficiency and/or chronic kidney disease (CKD). In addition, it Key words: chronic renal failure, calcium, calcitriol, phosphorus, para- is important to emphasize that in the PTG there is a In people with chronic kidney failure, treatment consists of dietary restriction of phosphorus; supplements containing an active form of vitamin D, such as calcitriol, doxercalciferol, paricalcitol; and phosphate binders, which are either calcium-based and non-calcium based. Secondary hyperparathyroidism occurs when the parathyroids are overfunctioning because something is causing chronic hypocalcemia (the “something” is usually chronic renal failure). The Role of PTH in Secondary Hyperparathyroidism (secondary HPT) Secondary HPT manifests as one of two types of renal osteodystrophy: either a high turnover state known as osteitis fibrosa, or, in combination with low bone turnover, known as mixed uremic osteodystrophy. Secondary hyperparathyroidism is a common complication of impaired renal function. Hyperparathyroidism is supported biochemically by either an elevated serum parathyroid hormone level or an inappropriately normal level in the setting of hypercalcemia. The most common causes of secondary hyperparathyroidism are kidney failure and vitamin D deficiency. The role of the surgical pathologist in the evaluation of secondary hyperparathyroidism is basically to identify parathyroid tissue at the time of frozen section to allow for the surgeon to remove portions of this tissue for autotransplantation. Hyperparathyroidism is relatively common. Secondary Hyperparathyroidism Pathogenesis and Patterns of Parathyroid Hyperplasia. Total body phosphorus burden and increasing concentration of circulating phosphorus play a pivotal role in the development of renal secondary hyperparathyroidism and are intimately related to dynamics of calcitriol and FGF-23. Function… The only function of the parathyroid gland is to manage calcium levels within the blood; … Secondary hyperparathyroidism (HPT) is common in chronic kidney disease (CKD) as the result of a multitude of metabolic derangements. High blood calcium over a number of years can cause kidney failure (renal failure). The secretion of hormone by the hyperplastic parathyroid gland usually remains responsive to fluctuations in blood Ca 2+ . Renal secondary hyperparathyroidism is a complex, multifactorial syndrome that involves changes in circulating levels of calcium, PTH, phosphorus, and 1,25-dihydroxycholecalciferol (calcitriol). These changes are linked to shorter survival and hardening of the arteries leading to heart disease. Secondary hyperparathyroidism is a condition in which a disease outside of the parathyroid glands causes all of the parathyroid glands to become enlarged and hyperactive.  Renal secondary hyperparathyroidism is a complex, multifactorial syndrome that involves changes in circulating levels of calcium, PTH, phosphorus, and 1,25-dihydroxycholecalciferol (calcitriol). The National Kidney Foundation is the leading organization in the U.S. dedicated to the awareness, prevention and treatment of kidney disease for hundreds of thousands of healthcare professionals, millions of patients and their families, and tens of millions of Americans at risk. It is important to treat secondary hyperparathyroidism to prevent it from causing other health problems, such as bone disease. secondary hyperparathyroidism. Hyperparathyroidism secondary to chronic renal failure is a condition characterized by inappropriate secretion of parathyroid hormone (PTH), secondary to a phosphocalcic metabolic disorder. PMID: 22399154. If the underlying cause of the hypocalcemia can be addressed, the hyperparathyroidism will resolve. Two types of hyperparathyroidism exist. However, the term is more generally used to encompass the biochemical abnormalities of CKD-MBD (ie, calcium, phosphate, PTH, vitamin D). Overview. Secondary hyperparathyroidism occurs when the parathyroid glands become enlarged and release too much PTH, causing a high blood level of PTH. Secondary hyperparathyroidism due to renal failure can often be controlled with a medication called cinacalcet. Secondary hyperparathyroidism refers to the biochemical abnormalities that characterize CKD-MBD. PTH is a chemical messenger, produced by the parathyroid glands to control calcium and phosphate levels in our blood and calcium levels in our bones. Kidney: chronic renal failure - interstitial nephritis 02. N25.81 is a billable diagnosis code used to specify a medical diagnosis of secondary hyperparathyroidism of renal origin. Secondary Hyperparathyroidism: The parathyroids are four glands in the neck that produce parathyroid hormone to help control calcium metabolism. Secondary hyperparathyroidism (SHPT) is one of the most common complications in patients with chronic kidney disease (CKD) and end stage renal disease (ESRD). Secondary hyperparathyroidism means the parathyroid glands are overproducing parathyroid hormone in an attempt to help the body increase the amount of calcium in the blood.It is the only job of the parathyroid glands to maintain normal calcium levels and the four parathyroid glands will increase the production of their hormone (parathyroid hormone PTH) if the calcium is too low. 2016).Secondary hyperparathyroidism has an external etiology and can be caused by vitamin D deficiency, liver disease, lithium therapy or, most commonly, chronic kidney disease (CKD). There are several reasons why this happens in patients with kidney disease: Higher blood phosphorus levels The kidneys cannot make active vitamin D (needed to absorb calcium) Goldfarb M, Gondek SS, Lim SM, Farra JC, Nose V, Lew JI. In Secondary Hyperparathyroidism, you will have a low or normal calcium level with a raised parathyroid hormone level. In primary hyperparathyroidism, an enlargement o… Primary hyperparathyroidism originates within the parathyroid gland itself and can be due to glandular hyperplasia or neoplasia. ";s:7:"keyword";s:35:"renal secondary hyperparathyroidism";s:5:"links";s:525:"<a href="http://truck-doctor.com/e590c6p/dana-point-ferry-to-catalina">Dana Point Ferry To Catalina</a>,
<a href="http://truck-doctor.com/e590c6p/examples-of-welfare-abuse">Examples Of Welfare Abuse</a>,
<a href="http://truck-doctor.com/e590c6p/lands-of-lore-dagger-in-dagger-out">Lands Of Lore Dagger In Dagger Out</a>,
<a href="http://truck-doctor.com/e590c6p/circle-k-easy-rewards-card">Circle K Easy Rewards Card</a>,
<a href="http://truck-doctor.com/e590c6p/chvostek-sign-pronunciation">Chvostek Sign Pronunciation</a>,
";s:7:"expired";i:-1;}